Could a nasal spray boost social skills in kids with autism?

NCT ID NCT03204786

Completed Symptom relief Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a nasal spray containing vasopressin, a natural hormone, can improve social functioning in children with autism. 157 children aged 6 to 17 took part. Researchers measured changes in social responsiveness and overall symptoms over 8 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: vasopressin nasal spray
What this could lead to: If it works, this could offer a new way to improve social communication in children with autism.
What could go wrong: This is an early-stage trial with mixed results. The hormone may not work for everyone, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial septal defect autism autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASD AUTISM AUTISM SPECTRUM DISORDER

Contacts and locations

Locations

Stanford University

Stanford, California, 94305-5719, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.